Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Jun 22.
Published in final edited form as: Vascul Pharmacol. 2006 Jan 20;44(3):131–142. doi: 10.1016/j.vph.2005.10.005

Vascular calcium channels and high blood pressure: Pathophysiology and therapeutic implications

Swapnil Sonkusare a, Philip T Palade a, James D Marsh b, Sabine Telemaque b, Aleksandra Pesic a, Nancy J Rusch a,*
PMCID: PMC4917380  NIHMSID: NIHMS795738  PMID: 16427812

Abstract

Long-lasting Ca2+ (CaL) channels of the Cav1.2 gene family are heteromultimeric structures that are minimally composed of a pore-forming α1C subunit and regulatory β and α2δ subunits in vascular smooth muscle cells. The CaL channels are the primary pathways for voltage-gated Ca2+ influx that trigger excitation–contraction coupling in small resistance vessels. Notably, vascular smooth muscle cells of hypertensive rats show an increased expression of CaL channel α1C subunits, which is associated with elevated Ca2+ influx and the development of abnormal arterial tone. Indeed, blood pressure per se appears to promote CaL channel expression in small arteries, and even short-term rises in pressure may alter channel expression. Membrane depolarization has been shown to be one stimulus associated with elevated blood pressure that promotes CaL channel expression at the plasma membrane. Future studies to define the molecular processes that regulate CaL channel expression in vascular smooth muscle cells will provide a rational basis for designing antihypertensive therapies to normalize CaL channel expression and the development of anomalous vascular tone in hypertensive pathologies.

Keywords: Calcium channels, Hypertension, Blood pressure, Ion channel expression, Vascular smooth muscle, Microcirculation

1. Introduction

Chronic hypertension is one of the deadliest diseases in the United States, predisposing 45 million individuals to ventricular hypertrophy, heart failure, stroke and end-stage renal damage. In all but rare cases, the etiology is unknown and the disease is thought to evolve from the interaction of multiple genes with environmental factors. Indeed, numerous pathways involving endocrine factors, neural reflexes and vascular abnormalities are thought to contribute to essential hypertension. However, regardless of these diverse origins, one hallmark finding in all forms of hypertension is an anomalous vascular tone that is mediated by Ca2+ influx through voltage-gated, “L-type” Ca2+ (CaL) channels. Under optimal conditions, the low open-state probability of CaL channels in the vascular smooth muscle cells (VSMCs) is designed to tightly regulate Ca2+ influx, vascular tone, and blood pressure. However, this process may go awry during the pathogenesis of hypertension in which an increased Ca2+ influx may fuel the development of an abnormal vascular tone and elevated peripheral vascular resistance.

Notably, our knowledge of cardiovascular CaL channels has been revolutionized in the past two decades by the availability of molecular biology, protein crystallographic and patch-clamp techniques. This knowledge has laid the foundation for understanding the relationship between the structure and function of CaL channels in the vasculature and the regulation of blood pressure. In this regard, studies from a number of laboratories have revealed that hypertension is associated with an upregulation of CaL channels in vascular beds involved in regulating blood pressure and adjusting blood flow to critical organs. The fact that this CaL channel abnormality extends to several animal models of hypertension infers that it may represent a common event in the pathogenesis of different forms of the disease. To provide a synopsis of the recent evidence linking CaL channel abnormalities to hypertension, this brief review will initially discuss the structure, distribution and function of CaL channels in the vasculature. Subsequently, it will summarize the recent findings indicating that CaL channels may be involved in the pathogenesis of hypertension. A final section will identify emerging opportunities to design new classes of antihypertensive drugs that target specific promoters or subunits of the vascular CaL channels.

2. Structure and classification

Voltage-dependent Ca2+ channels are required for normal excitation–contraction coupling in the heart, skeletal muscle and various types of smooth muscle including vascular smooth muscle cells (VSMCs). Initial purification studies using skeletal muscle revealed that voltage-gated Ca2+ channels were multi-subunit complexes, composed of a central pore-forming α1 subunit and additional β, α2δ and γ subunits (Fig. 1A) (Curtis and Catterall, 1984, 1985; Hosey et al., 1987; Ice et al., 1987; Leung et al., 1987; Vaghy et al., 1987). It is now known that the large (≈190–240 kDa) α1 subunit confers most functional properties to the CaL channel, including voltage sensing, Ca2+ permeability, Ca2+-dependent inactivation, and inhibition by Ca2+ channel blockers. The structure of the α1 subunit includes four repeat domains (I, II, III, IV) each composed of 6 transmembrane segments (Catterall, 2000; Jurkat-Rott and Lehmann-Horn, 2004). Modulation of channel behavior by phosphorylation is enabled by intracellular binding domains for signaling molecules including protein kinase A (PKA) and protein kinase C (PKC). In addition, the amino (N)-and carboxy (C)-termini play specific roles in modulating channel phenotype and expression. For example, the C-terminus has been implicated in Ca2+-dependent signal transduction including the constitutive binding of calmodulin to permit Ca2+-dependent inactivation of the channel (Kobrinsky et al., 2005; Lee et al., 1999; Liang et al., 2003; Peterson et al., 1999; Qin et al., 1999; Zuhlke et al., 1999).

Fig. 1.

Fig. 1

(A) Proposed membrane topology of the L-type Ca2+ (CaL) channel. The central α1 subunit is a single large polypeptide of 4 repeat domains (I–IV). The intracellular linkers and N- and C-termini of the α1 subunit interact with β subunits and intracellular signaling molecules. Genes for four β subunits (β1, β2, β3, β4) have been identified, and four splice variants of the α2δ subunit exist. A γ subunit has been detected in skeletal muscle and brain. Abbreviations: AID, alpha interactive domain; BID, beta interactive domain; CaM, calmodulin; PKA, protein kinase A; PKC, protein kinase C. (B) Linear model of amino acids in the domains of a β subunit. The β subunits possess a guanylate kinase (GK) region that contains the beta interactive domain (BID), and a Src homology 3 (SH3) domain that may interact with the GK region to permit binding between the α1 and β subunits.

Although the α1 subunit determines the signature properties of the CaL channel, the intracellular β subunits modulate the biophysical and physiological responses. The β subunits belong to the membrane-associated guanylate kinase (MAGUK) family of scaffolding proteins, which possess a guanylate kinase (GK) and a Src homology 3 (SH3) domain (Fig. 1B) (Cohen et al., 2005). The GK region of the β subunit contains a beta interactive domain (BID), which along with other subunit sites, is required for high affinity interaction with the alpha interactive domain (AID) of the α1 subunit (Berjukow et al., 2001; Birnbaumer et al., 1998; Catterall, 2000; Chen et al., 2004; Dolphin, 2003; Geib et al., 2002). Mutations that disrupt the SH3–GK interactions within the β subunits inhibit their binding to the α1 subunit and prevent normal channel gating (Harry et al., 2004; McGee et al., 2004). As scaffolding proteins, the β subunits may localize and integrate intracellular signals to influence CaL channel gating (Balijepalli et al., 2003). For example, phosphorylation of the β subunit by PKA is considered to be responsible for PKA-induced stimulation of cloned Ca2+ channels in HEK cells co-transfected with α1C and β2a subunits (Bunemann et al., 1999).

Notably, the heterogeneous nature of the β subunits has hindered efforts to define their function. Four different genes (β1, β2, β3, β4) and extensive splice variants of each gene exist (Foell et al., 2004; Harry et al., 2004; Kamada et al., 2004) that distinctly modify activation and inactivation kinetics, (Berjukow et al., 2001; Berrou et al., 2001; Berrow et al., 1995; Chen et al., 2004; Geib et al., 2002), voltage gating (Berrow et al., 1995; Birnbaumer et al., 1998; Catterall, 2000), and drug sensitivity (Berrow et al., 1995; Dolphin, 2003; Wei et al., 1995). For example, although the α1 subunit contains inherent determinants of voltage-dependent inactivation (Cens et al., 1999; Herlitze et al., 1997; Spaetgens and Zamponi, 1999; Zhang et al., 1994), association with different β subunit isoforms may either increase or decrease its overall inactivation rate (Meir and Dolphin, 2002; Olcese et al., 1994). Importantly, all four β subunits generate a molecular signal for correct plasma membrane targeting of functional Ca2+ channel complexes, and thereby can profoundly affect the level of Ca2+ influx during cell depolarization (Birnbaumer et al., 1998; Bogdanov et al., 2000; Brice et al., 1997; Canti et al., 2000; Chien et al., 1996, 1998; Dolphin, 2003; Kobrinsky et al., 2004).

The expression and function of the α1 subunit also depend on association with the α2δ subunits. Four distinct α2δ subunits (α2δ1, α2δ2, α2δ3, α2δ4) arise from alternative splicing of a single gene (Klugbauer et al., 2003; Marais et al., 2001), and a post-translational disulfide linkage results in a membrane-delineated dimer (De Jongh et al., 1990; Jay et al., 1991). Although the δ subunit is the portion of the protein that is anchored in the membrane, the extracellular α2 subunit also interacts with the α1 subunit (Gurnett et al., 1997). Co-expression of the α2δ subunits with cloned α1 subunits leads to accelerated channel gating, a hyperpolarizing shift in voltage activation, and enhanced channel expression (Klugbauer et al., 2003). The latter effect may rely, at least in part, on the presence of the β subunits, although there is no direct evidence for interactions between these ancillary subunits (Gerster et al., 1999; Klugbauer et al., 2003; Sipos et al., 2000).

The α1 subunits expressed in skeletal muscle and neurons also co-purify with γ subunits, which are membrane-delineated glycoproteins with 4 transmembrane segments (Arikkath and Campbell, 2003; Dolphin, 2003). Although the γ subunits show a wide tissue distribution, whether they co-assemble with α1 subunits in other cell types is still controversial (Kang et al., 2001; Klugbauer et al., 2000; Moss et al., 2002). To date, no association between the α1 and γ subunits has been described in cardiovascular tissues.

3. CaL channels in vascular smooth muscle

Initial studies indicate that the subunit composition of vascular CaL channels is a determinant of arterial tone and blood pressure levels. Functionally, these CaL channels show a unitary conductance between 20 and 30 pS, and are highly susceptible to block by nifedipine and other 1,4-dihydropyr-idine antagonists. Modeling studies of CaL currents in VSMCs suggest that at least several thousand pore-forming Ca2+ channel subunits are expressed in a single cell (Nelson et al., 1990). These channels inactivate slowly during sustained depolarization, so that the voltage-dependent Ca2+ influx permitted by a small fraction of these channels is sufficient to mediate pressure-induced constriction in small arteries and contribute to dynamic autoregulation in the coronary, cerebral and renal vascular beds (Gauthier-Rein and Rusch, 1998; Goligorsky et al., 1995; Inscho et al., 1998; Narayanan et al., 1994; Nelson et al., 1990). Thus, sustained voltage-dependent Ca2+ influx through the CaL channels maintains a tonic level of vasoconstriction and also provides an excitatory template upon which endogenous vasoactive substances may act to further modulate arterial diameter.

Surprisingly, despite their critical role in regulating excitation–contraction coupling in VSMCs, the exact subunit composition of vascular CaL channel complexes remains relatively obscure. In this regard, it appears that the CaL channels in VSMCs are minimally composed of α1, β and α2δ subunits. Some of the corresponding transcripts and proteins have been detected in a variety of arterial tissues (Table 1). In addition, gene deletion studies in mice have provided initial insight into the contributions of the α1C and β subunits to arterial tone and blood pressure levels (Table 2). Not surprisingly, the α1C subunit plays a key role in mediating vascular reactivity. For example, depolarization-induced contraction and myogenic tone are abolished in the arteries of mice showing smooth muscle-specific inactivation of the α1C (CaV1.2) gene. In these animals, the blood pressure level is reduced by ~30 mm Hg (Moosmang et al., 2003). Importantly, the α1C subunit in VSMCs represents a smooth muscle splice variant (α1C-b) that differs in four regions from the splice variant (α1C-a) expressed by cardiac myocytes (Liao et al., 2004; Welling et al., 1997). Most notably, alternative splicing of exon 8 results in amino acid differences in transmembrane segment IS6 that confer an increased sensitivity for 1,4-dihydropyridine drugs to the vascular variant (Liao et al., 2004; Welling et al., 1997). Furthermore, alternative splicing of exon 1 results in a shorter N-terminus of the α1C subunits in VSMCs compared to cardiac myocytes (Saada et al., 2003). This arrangement may permit a separate promoter to selectively regulate the availability of vascular CaL channels without altering expression levels in other tissues affected by the same stimuli (Pang et al., 2003; Saada et al., 2003).

Table 1.

Transcript and protein expression of L-type Ca2+ (CaL) channel subunits detected in the vasculature

Subunit Human chromosomal location Vascular expression
mRNA Protein Preparation
α1C (CaV1.2) 12p13.3 Yes Human aortaa,b
Yes Yes Mouse aortac,d
Yes Yes Rat aortae,f
Yes Yes Rat mesenteric arteryg
Yes Yes Rat femoral arteryg
Yes Yes Rat renal arteryh,i
Yes Yes Pig coronary arteryj
Yes Pig pulmonary arteryk
*Not inclusive of all studies
β1 17q21–q22 Yes Rat renal arteryi
β2 10p12 Yes Yes Mouse aortac
Yes Rat renal arteryi
Yes Yes Pig pulmonary arteryk
β3 12q13 Yes Yes Mouse aortac
Yes Yes Rabbit aortal
Yes Rat renal arteryi
β4 2q22–q23 Yes Rat renal arteryi
α2δ-1 7q21–q22 Yes Yes Human aortam,n
α2δ-2 3p21.3 Yes Yes Human aortam
α2δ-3 3p21.1 ???
α2δ-4 12p13.3 ???

Table 2.

Cardiovascular effects of deletion of specific Ca2+ channel subunits in mice

Subunit deletion Survival Cardiovascular effect
α1C (smooth-muscle specific, inducible knockout) Yesa Tibial arteries show loss of CaL current in VSMCs, loss of myogenic tone and depolarization-induced contraction; blood pressure is low
β1 (conventional knockout) Die at birth of asphyxiab ?????
β2 (conventional knockout) Embryonic lethalc ?????
β2 (retain expression in heart) Yesc ?????
β3 (conventional knockout) Yesd Reduced CaL current in aortic VSMCs, blood pressure is normal

Based on the initial detection of multiple ancillary subunits of the CaL channel in arterial tissues, a diverse population of heteromultimeric Ca2+ channels is anticipated. Transcripts encoding all four β subunits (β1, β2, β3, β4) have been detected in VSMCs, although only the corresponding proteins for the β2 and β3 subunits have been reported (Table 1). Indeed, the β1 and β4 subunits appear to be primarily expressed in tissues outside the vasculature, including skeletal muscle and neurons, respectively (Gregg et al., 1996; Pichler et al., 1997). Thus, mice lacking the β1 subunit die at birth from asphyxia (Gregg et al., 1996), reflecting the requisite role of the β1 subunit in excitation–contraction coupling in skeletal muscle (Table 2). In contrast, conventional knockout of the gene encoding the β2 subunit in mice results in embryonic lethality presumably from a cardiac defect since a transgenic and cardiac-specific rescue of the β2 subunit permits survival (Ball et al., 2002). In the latter animals, future studies on the functional impact of β2 subunit deletion may provide initial insights into the influence of the β2 subunit on vascular CaL channel expression and the generation of arterial tone. Notably, gene deletion studies in β3 knockout mice in which the expression of the β2 subunit is maintained have inferred dual functional roles for the vascular β2 and β3 subunits (Murakami et al., 2003; Muth et al., 2001). In these animals, aortic VSMCs lacking the β3 subunit show a 30% reduction in voltage-gated Ca2+ current, indicating that β3 subunits contribute to the expression of functional α1C subunits in the plasma membrane. In the same animals, the presence of residual CaL current in the VSMCs after deletion of the β3 gene is interpreted to infer a redundant role for the β2 subunit in α1C trafficking and the maintenance of CaL channel expression (Murakami et al., 2003).

4. Role of CaL channels in the pathogenesis of hypertension

Abnormalities of Ca2+ channels are regarded as part of the extensive biological and morphological adaptations that characterize the vasculature during the pathogenesis of hypertension. Initially, during acute increases in blood pressure, small arteries and arterioles show an immediate “stretch-dependent” depolarization and constriction commonly referred to as the “myogenic” response. The myogenic response relies on the opening of CaL channels in the VSMCs for contraction (Nelson et al., 1990; Wang et al., 1999). In fact, the requisite role of CaL channels in mediating pressure-induced contraction is evident by the absence of myogenic tone in the arteries of mice in which the CaL channel (CaV1.2) gene is inactivated (Moosmang et al., 2003). Importantly, the myogenic response may be viewed as either a contributing or protective influence in hypertension (Cox and Rusch, 2002). On the one hand, the myogenic response of the small arteries and arterioles may amplify the initial rise in blood pressure and further elevate peripheral vascular resistance and blood pressure levels. Alternatively, in the cerebral, coronary and renal circulations that are primarily involved in the autoregulation of local blood flow, the myogenic response is postulated to dampen the transmission of the high systemic pressure to the microvasculature of the brain, heart and kidneys, respectively, thereby preventing pressure-induced damage to the capillary beds. Indeed, the loss of myogenic tone in the renal circulation has been linked to renal injury in animals and in humans with hypertension (Dworkin and Feiner, 1986; Feld et al., 1977; Gebremedhin et al., 1990; Hayashi et al., 1992, 1996; Olson et al., 1986), and also appears to precede the occurrence of hemorrhagic stroke in rats that are genetically predisposed to develop hypertension (Smeda and King, 2003).

The myogenic response of the different vascular beds continues to play a central role in regulating blood pressure levels and organ blood flow during the progression of hypertension. However, if blood pressure is not restored to normal levels by compensatory neural and renal mechanisms, the VSMCs of the arterial circulation appear to “electrically remodel” as an adaptive response to sustain the higher levels of voltage-gated Ca2+ influx required for persistent arterial contraction. This adaptation is postulated to rely, at least in part, on the development of a “disease-specific” profile of vascular ion channels that promotes arterial contraction and Ca2+ influx (Cox and Rusch, 2002). To date, two fundamental events have been implicated as the cellular mechanisms that evolve to sustain an elevated level of voltage-gated Ca2+ influx and contractile activation in VSMCs exposed to chronic increases in intravascular pressure. First, a loss of resting membrane K+ conductance resulting in depolarization-induced opening of CaL channels has been observed in VSMCs from several rat models of hypertension (Harder et al., 1983; Harder et al., 1985; Stekiel et al., 1986; Stekiel et al., 1993). Second, even short-term exposure to high intravascular pressures appears to upregulate the α1C subunit and the number of functional CaL channels in VSMCs (Lozinskaya and Cox, 1997; Martens and Gelband, 1996; Pesic et al., 2004; Simard et al., 1998; Wilde et al., 1994). Interestingly, new evidence suggests that depolarization per se promotes α1C subunit expression in the VSMCs of small arteries, suggesting that this “myogenic stimulus” may both activate existing CaL channels and increase the number of CaL channels in VSMCs during the evolution of hypertension (Pesic et al., 2004). Thus, poorly controlled hypertension in humans may beget further hypertension, a clinical syndrome that is unfortunately common.

5. Membrane depolarization activates vascular Ca2+ channels

Harder et al. (1983, 1985) initially reported that VSMCs in small cerebral arteries of spontaneously hypertensive rats (SHR) were depolarized and generated Ca2+-dependent action potentials indicative of an abnormally low permeability of the plasma membrane to K+ ions. Subsequently, a loss of resting K+ efflux resulting in membrane depolarization was found to be a common feature of VSMCs in a variety of vascular beds exposed to high blood pressure in vivo. For example, microelectrode studies in situ indicate that the resting membrane potential of mesenteric arteries is −38 mV in spontaneously hypertensive rats (SHR) compared to −43 mV in similar arteries of normotensive Wistar–Kyoto (WKY) rats (Stekiel et al., 1986). Similarly, cremaster arteries of renal hypertensive rats show a resting membrane potential of −40 mV compared to −44 mV in similar arteries of control rats (Stekiel et al., 1993). In view of the steep and positive relationship between resting membrane potential and vascular diameter at these voltages, even a loss of a few millivolts in membrane potential is predicted to activate CaL channels and accentuate voltage-gated Ca2+ influx into VSMCs to cause graded contraction.

The ionic changes that reduce the resting membrane potential of VSMCs during hypertension appear to involve a downregulation of voltage-gated K+ (KV) channels in the arterial plasma membranes exposed to high blood pressure (Cox et al., 2001; Martens and Gelband, 1996; Wang et al., 1997; Yuan et al., 1998a,b). Specifically, a loss of Shaker-type KV channels that contribute to the resting K+ efflux has been detected by patch-clamp studies in the VSMCs of SHR (Tobin et al., 2004). Additionally, the higher intraluminal pressure and enhanced sympathetic neural output that is characteristic of hypertensive animals may promote arterial depolarization and activation of voltage-gated CaL channels. The final consequence may be a Ca2+-dependent increase in peripheral vascular resistance that contributes to the progression of blood pressure elevation. However, a reduced membrane potential cannot explain why CaL current measured by patch-clamp methods is abnormally elevated in VSMCs from hypertensive animals. Since membrane potential is tightly controlled by this method, the persistence of an elevated Ca2+ current in the VSMCs of hypertensive animals suggests an inherent increase in CaL channel expression or activity (Cox and Lozinskaya, 1995; Lozinskaya and Cox, 1997; Ohya et al., 1993, 1998; Pesic et al., 2004; Simard et al., 1998).

6. Upregulation of CaL channels in response to high blood pressure

An enhanced voltage-gated Ca2+ current attributable to an increased number of CaL channels has been reported in the cerebral, mesenteric and renal VSMCs of SHR that exhibit a genetic form of hypertension. The elevated CaL current has been detected early in the development of hypertension, and does not appear to correspond to an altered voltage-sensitivity of the channel (Lozinskaya and Cox, 1997; Ohya et al., 1993). Rather, single-channel recordings have detected an increased number of CaL channel openings without evidence of altered single-channel conductance or open-time distribution (Ohya et al., 1998). All of these findings are consistent with the hypothesis that an increased number of functional CaL channel proteins rather than altered channel properties may account for the elevated CaL current in the VSMCs of the SHR.

In this regard, Western blots have confirmed an increased expression of the pore-forming α1C subunit of the CaL channel in arteries of adult SHR compared to age-matched WKY rats with normal blood pressure levels (Pratt et al., 2002). Indeed, a panel of arteries from the two rat strains indicates an overabundance of α1C subunits in the mesenteric, femoral and renal circulations of the SHR, suggesting that this abnormality extends to at least several vascular beds (Fig. 2). Notably, in the renal, mesenteric and skeletal muscle circulations, the increased expression of α1C subunits corresponds to a higher density of CaL current and the development of anomalous vascular tone (Cox and Lozinskaya, 1995; Lozinskaya and Cox, 1997; Ohya et al., 1993, 1998; Pesic et al., 2004; Pratt et al., 2002). For example, in the renal arteries of adult SHR, an increased expression of α1C subunits is associated with an enhanced Ca2+ current and an accentuated Ca2+-dependent spontaneous tone that is reversed by treatment with nifedipine, a CaL channel blocker (Fig. 3A,B,C).

Fig. 2.

Fig. 2

Immunoblot showing that the α1C subunit (200–240 kDa) is more highly expressed in the mesenteric, femoral and renal arteries of SHR compared to WKY rats. The doublet bands represent the long and short forms of the subunit. α-Actin was used as a loading control and appears as a 45-kDa band.

Fig. 3.

Fig. 3

Renal arteries of SHR show an increased expression and function of the CaL channel α1C subunit. (A) The α1C subunit is more highly expressed in renal arteries of SHR compared to WKY rats. (B) Whole-cell Ca2+ currents elicited by 8-mV steps from −70 mV to +20 mV were higher in renal VSMCs of SHR compared to WKY rats. (C) Tension-recording traces in isolated renal arteries of WKY and SHR maintained in drug-free physiological salt solution (PSS). The arteries of SHR developed more Ca2+-dependent tone, which was reversed by 1 μmol/L nifedipine. Adapted with permission from Pratt et al. (2002).

Interestingly, the membrane density of CaL current in VSMCs from either the SHR or WKY rat strain appears to be proportional to blood pressure levels, suggesting that the genetic background of the SHR is not required for CaL channel overexpression. For example, a close linear correlation exists between systolic blood pressure and Ca2+ current density in VSMCs isolated from small mesenteric arteries of either WKY rats or SHR during natural development (Lozinskaya and Cox, 1997). Also, the treatment of SHR with the angiotensin converting enzyme inhibitor, ramipril, decreased both systolic blood pressure and Ca2+ current density concurrently in mesenteric VSMCs (Cox et al., 2002). These data suggest a strong, positive relationship between blood pressure and the number of functional CaL channels in the vasculature in vivo and raise the intriguing possibility that high blood pressure per se may promote the expression of the α1C subunit in the arterial circulation.

Recently, the hypothesis that high blood pressure induces vascular CaL channel expression was directly tested in the renal circulation of the aortic-banded rat. In this model of hypertension, the aorta is surgically banded between the right renal (RR) and left renal (RR) arteries resulting in the selective elevation of blood pressure in the right renal circulation located proximal to the banded site (Fig. 4 [inset]). Although the right and left renal circulations of these animals were exposed to the same genetic and neuroendocrine influences, the expression of the α1C subunit was profoundly higher in the vasculature of the right kidney exposed to an elevated level of blood pressure for 4 weeks (Fig. 4A). In the same animals, patch-clamp recordings verified that the appearance of the α1C subunit was associated with an increased CaL current in the VSMCs of the right renal circulation and the corresponding small arteries spontaneously developed vascular tone that was reversed by nifedipine (Fig. 4B,C). Interestingly, exposure of the right renal circulation to higher blood pressure levels of ~150 mm Hg for as little as 2 days was observed to cause an increased expression of the α1C subunit in the affected arteries (Pesic et al., 2004). These recent findings have provided strong evidence that the upregulation of the α1C subunit by high blood pressure in vivo increases the availability of functional CaL channels in renal VSMCs, and even short-term increases in blood pressure may rapidly enhance CaL channel expression.

Fig. 4.

Fig. 4

Aortas of Sprague–Dawley rats were banded between the renal arteries to establish high blood pressure in the right renal circulation proximal to the banded site (inset). Four weeks later, renal arteries were microdissected from the right and left kidneys of the same animal for analysis. (A) The α1C subunit was more highly expressed in the right renal (RR) arteries exposed to high blood pressure than in the left renal (LR) arteries. (B) Whole-cell Ca2+ currents elicited by 8-mV steps from −70 mV to +50 mV were higher in renal VSMCs of RR compared to LR arteries. (C) The RR arteries developed more Ca2+-dependent tone than the LR arteries in drug-free physiological salt solution (PSS), which was reversed by 1 μmol/L nifedipine. Adapted with permission from Pesic et al. (2004).

7. How does high blood pressure induce CaL channel expression?

Although the stimuli that link the development of high blood pressure to CaL channel expression remain unclear, at least two reports have indicated that a reduced membrane potential may be a key factor that promotes the expression of the α1C subunit in the plasma membrane of VSMCs (Ruiz-Velasco et al., 1994; Pesic et al., 2004). In the latter study, renal arteries from normal rats were incubated for 48 h in culture media containing either a physiological level of K+ (4 mmol/L) to maintain normal membrane potential, or media containing a higher K+ concentration (30 mmol/L) to depolarize the VSMCs. Under these conditions, the α1C subunit was profoundly upregulated in the arteries exposed to the depolarizing media for 48 h, and the affected VSMCs showed an increased density of Ca2+ current indicative of an enhanced abundance of functional CaL channels (Fig. 5A,B). Thus, membrane depolarization, which has long been recognized as a characteristic feature of VSMCs exposed to high blood pressure, appears to dynamically upregulate the number of vascular CaL channels (Fig. 5C). Although there are few clues regarding other endogenous signals that may regulate CaL channel expression in the vasculature, a number of physiological influences including electrical activity, catecholamines, glucocorticoids, testosterone, and intracellular calcium modulate the expression of the cardiac CaL channel isoform (Avila et al., 2001; Davidoff et al., 1997; Maki et al., 1996; Nattel and Li, 2000; Takimoto et al., 1997). Thus, it seems plausible that CaL channel expression in the vasculature is dynamically determined by complex interactions between blood pressure and the multiple genetic and neuroendocrine influences that impinge on small arteries and arterioles in vivo.

Fig. 5.

Fig. 5

Isolated renal arteries of control Sprague–Dawley rats were incubated for 48 h in control (Ctrl) or depolarizing (Depol.) media. (A) The CaL channel α1C subunit was more highly expressed in the arteries depolarized for 48 h. (B) Whole-cell Ca2+ currents elicited by 8-mV steps from −70 mV to +50 mV were higher in renal VSMCs of depolarized compared to control arteries. (C) Cartoon suggesting that depolarization results in the upregulation of α1C subunits in VSMC membranes. The mechanism has not been delineated. Adapted with permission from Pesic et al. (2004).

In this regard, the expression of the α1C subunit appears to be regulated at multiple steps that ultimately culminate in CaL channel formation. Small increases in transcript levels encoding the α1C subunit have been detected in the mesenteric and femoral arteries of SHR that exhibit an accentuated expression of functional CaL channels (Pratt et al., 2003). However, the relatively small increases in α1C transcript do not appear to fully account for the striking abundance of the α1C protein in the arteries of the SHR, or the pronounced increases in CaL current in the corresponding VSMCs (Cox and Lozinskaya, 1995; Lozinskaya and Cox, 1997; Ohya et al., 1993, 1998; Pesic et al., 2004; Pratt et al., 2002; Simard et al., 1998). For this reason, it is likely that events that enhance CaL channel translation, translocation or stability in the plasma membrane also are operational in SHR arteries. Unfortunately, there is little information regarding the translational processes that regulate the formation of CaL channel subunits in VSMCs. The sole observation that the α1C transcript is affected by cAMP may indicate a possible influence of endogenous substances on transcriptional processes (Xie et al., 1999). Similarly, little is known regarding the mechanisms that regulate CaL channel stability or degradation, although one report indicates that the α1C subunit has a short, 3-h half life in HEK cells (Chien et al., 1995). Additionally, proteolytic carboxy terminal truncation of α1C in myometrial smooth muscle may be affected by estrogen and progesterone (Helguera et al., 2002).

One process that has drawn close attention is the interaction between α and β subunits in the endoplasmic reticulum (ER) that enables transport of the α/β channel complex to the plasma membrane to form more functional CaL channels (Herlitze et al., 2003; Hullin et al., 2003). A disruption of this process is thought to reduce CaL channel formation in some forms of heart failure, resulting in a decline in Ca2+ entry and cell contractility (Fan et al., 2003). Trafficking of α1C also can be affected by PI3K and Akt/PKB in a β2 subunit-dependent fashion (Viard et al., 2004), and by the interaction of β subunits with Rem and Rad GTPases (Beguin et al., 2001; Finlin et al., 2003). However, whether these β subunit-mediated pathways for regulating α1C trafficking are functional in VSMCs remains unknown.

8. Implications for antihypertensive therapies

Recent evidence suggests that the development of anomalous arterial tone during hypertension is associated with an increased expression of vascular CaL channels that are minimally composed of α1C, β and α2δ subunits. Importantly, the α1C subunit is the binding site for all three of the classes (dihydropyridines, phenylalkylamines and benzothiazipines) of organic Ca2+ channel blockers (CCBs) that are used to treat essential hypertension in humans. The interaction of these drugs with the α1C subunit reduces the open-state probability of the CaL channel and thereby attenuates the voltage-gated Ca2+ influx that is required for vascular activation. Fortuitously, the increased abundance of the vascular α1C subunits during hypertension may provide more binding sites for CCBs, thereby amplifying their vasodilator action proportional to blood pressure elevation. This may help to explain why CCBs effectively lower blood pressure in hypertensive animals and humans, but only mildly reduce blood pressure levels in normotensive individuals (Godfraind et al., 1991; Miyamori et al., 1987; Narita et al., 1983; Takata and Hutchinson, 1983).

However, it is estimated that blood pressure is fully normalized in only 20% to 30% of hypertensive patients because of poor compliance due to cost, side effects, drug interactions, and practical difficulties inherent in monitoring by physicians (Dustan, 1996; Mancia and Grassi, 2002; Waeber, 2002). Thus, there is an unmet need for longer-term antihypertensive treatment to avoid poor compliance and minimize the impact of chronic hypertension on the patient’s well being. In this regard, new therapeutics targeting vascular-specific CaL channel expression may have more enduring effects. The presence of multiple transcripts (Pang et al., 2003; Saada et al., 2003) and a vascular splice variant of the α1C subunit (Liao et al., 2004; Welling et al., 1997) may afford tantalizing opportunities to differentially downregulate the CaL channel in the vasculature to reduce blood pressure, while maintaining expression in the heart that relies on CaL channels for cardiac contraction. Furthermore, as the types of β and α2δ regulatory subunits in VSMCs become known, a number of new paradigms for reducing CaL channel expression or gating may emerge that will promote the design of new antihypertensive agents. First, unique CCBs that bind to the β or α2δ subunits to reduce CaL channel expression or gating may enact potent relaxation of VSMCs. Second, mutated β subunits have been designed that co-assemble with the α1C subunit in the endoplasmic reticulum but prevent its translocation to the plasma membrane. In cardiac cells, these agents reduce the excitation–contraction coupling that relies on Ca2+ entry through CaL channels, but do not disrupt the kinetics of contraction or relaxation (Fan et al., 2003). Exciting findings such as these indicate that the development of new classes of antihypertensive drugs will rely on identifying the subunit basis of CaL channels in the vasculature, and designing drugs to reduce their expression or activity.

9. Summary

Reports from a number of laboratories concur that voltage-gated Ca2+ influx through CaL channels is elevated in VSMCs from several rat models of hypertension. In the same rat strains, an overabundance of the CaL channel α1C subunits has been observed in several vascular beds that are involved in blood pressure regulation. Interestingly, it appears that high blood pressure per se promotes the expression of CaL channels in the VSMC membrane, and that even short-term rises in blood pressure in vivo are capable of increasing the number of CaL channels in small resistance arteries. A recent study suggests that the pressure-induced depolarization of VSMCs, which occurs during the development of hypertension, may provide an electrophysiological signal that triggers the upregulation of vascular CaL channels. Thus, blood pressure appears to represent an endogenous promoter of CaL channel expression in the arterial circulation, and new efforts are focused on identifying the molecular processes that mediate this event. These future studies, combined with a detailed knowledge of CaL channel structure in VSMCs, will set the stage for developing new antihypertensive drugs that reduce the expression or activity of the CaL channel to attenuate the anomalous vascular tone that is the hallmark finding of hypertensive disease.

Acknowledgments

The authors would like to thank Mr. Miodrag Pesic for assistance with manuscript and graphics preparation.

Research in the authors’ laboratories was supported in part by USPHS R01 HL-59238 (NJR), R01 HL-68406 (NJR), R01 HL63903 (PTP) and R01 HL073097 (PTP and JDM) from the USA National Institutes of Health.

References

  1. Arikkath J, Campbell KP. Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol. 2003;13:298–307. doi: 10.1016/s0959-4388(03)00066-7. [DOI] [PubMed] [Google Scholar]
  2. Avila G, O’Connell KM, Groom LA, Dirksen RT. Ca2+ release through ryanodine receptors regulates skeletal muscle L-type Ca2+ channel expression. J Biol Chem. 2001;276:17732–17738. doi: 10.1074/jbc.M009685200. [DOI] [PubMed] [Google Scholar]
  3. Balijepalli RC, Lokuta AJ, Maertz NA, Buck JM, Haworth RA, Valdivia HH, Kamp TJ. Depletion of T-tubules and specific subcellular changes in sarcolemmal proteins in tachycardia-induced heart failure. Cardiovasc Res. 2003;59:67–77. doi: 10.1016/s0008-6363(03)00325-0. [DOI] [PubMed] [Google Scholar]
  4. Ball SL, Powers PA, Shin HS, Morgans CW, Peachey NS, Gregg RG. Role of the β2 subunit of voltage-dependent calcium channels in the retinal outer plexiform layer. Invest Ophthalmol Visual Sci. 2002;43:1595–1603. [PubMed] [Google Scholar]
  5. Beguin P, Nagashima K, Gonoi T, Shibasaki T, Takahashi K, Kashima Y, Ozaki N, Geering K, Iwanaga T, Seino S. Regulation of Ca2+ channel expression at the cell surface by the small G-protein kir/Gem. Nature. 2001;411:701–706. doi: 10.1038/35079621. [DOI] [PubMed] [Google Scholar]
  6. Berjukow S, Marksteiner R, Sokolov S, Weiss RG, Margreiter E, Hering S. Amino acids in segment IVS6 and β-subunit interaction support distinct conformational changes during Cav2.1 inactivation. J Biol Chem. 2001;276:17076–17082. doi: 10.1074/jbc.M010491200. [DOI] [PubMed] [Google Scholar]
  7. Berrou L, Bernatchez G, Parent L. Molecular determinants of inactivation within the I–II linker of α1E (CaV2.3) calcium channels. Biophys J. 2001;80:215–228. doi: 10.1016/S0006-3495(01)76008-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Berrow NS, Campbell V, Fitzgerald EM, Brickley K, Dolphin AC. Antisense depletion of β-subunits modulates the biophysical and pharmacological properties of neuronal calcium channels. J Physiol. 1995;482:481–491. doi: 10.1113/jphysiol.1995.sp020534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Birnbaumer L, Qin N, Olcese R, Tareilus E, Platano D, Costantin J, Stefani E. Structures and functions of calcium channel β subunits. J Bioenerg Biomembranes. 1998;30:357–375. doi: 10.1023/a:1021989622656. [DOI] [PubMed] [Google Scholar]
  10. Bogdanov Y, Brice NL, Canti C, Page KM, Li M, Volsen SG, Dolphin AC. Acidic motif responsible for plasma membrane association of the voltage-dependent calcium channel β1b subunit. Eur J Neurosci. 2000;12:894–902. doi: 10.1046/j.1460-9568.2000.00981.x. [DOI] [PubMed] [Google Scholar]
  11. Bowles DK, Maddali KK, Ganjam VK, Rubin LJ, Tharp DL, Turk JR, Heaps CL. Endogenous testosterone increases L-type Ca2+ channel expression in porcine coronary smooth muscle. Am J Physiol. 2004;287:H2091–H2098. doi: 10.1152/ajpheart.00258.2004. [DOI] [PubMed] [Google Scholar]
  12. Brice NL, Berrow NS, Campbell V, Page KM, Brickley K, Tedder I, Dolphin AC. Importance of the different β subunits in the membrane expression of the α1A and α2 calcium channel subunits: studies using a depolarization-sensitive α1A antibody. Eur J Neurosci. 1997;9:749–759. doi: 10.1111/j.1460-9568.1997.tb01423.x. [DOI] [PubMed] [Google Scholar]
  13. Bunemann M, Gerhardstein BL, Gao T, Hosey MM. Functional regulation of L-type calcium channels via protein kinase A-mediated phosphorylation of the β2 subunit. J Biol Chem. 1999;274:33851–33854. doi: 10.1074/jbc.274.48.33851. [DOI] [PubMed] [Google Scholar]
  14. Canti C, Bogdanov Y, Dolphin AC. Interaction between G proteins and accessory β subunits in the regulation of α1B calcium channels in Xenopus oocytes. J Physiol. 2000;527:419–432. doi: 10.1111/j.1469-7793.2000.t01-1-00419.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol. 2000;16:521–555. doi: 10.1146/annurev.cellbio.16.1.521. [DOI] [PubMed] [Google Scholar]
  16. Cens T, Restituito S, Galas S, Charnet P. Voltage and calcium use the same molecular determinants to inactivate calcium channels. J Biol Chem. 1999;274:5483–5490. doi: 10.1074/jbc.274.9.5483. [DOI] [PubMed] [Google Scholar]
  17. Chen YH, Li MH, Zhang Y, He LL, Yamada Y, Fitzmaurice A, Shen Y, Zhang H, Tong L, Yang J. Structural basis of the α1-β subunit interaction of voltage-gated Ca2+ channels. Nature. 2004;429:675–680. doi: 10.1038/nature02641. [DOI] [PubMed] [Google Scholar]
  18. Chien AJ, Zhao X, Shirokov RE, Puri TS, Chang CF, Sun D, Rios E, Hosey MM. Roles of a membrane-localized β subunit in the formation and targeting of functional L-type Ca2+ channels. J Biol Chem. 1995;270:30036–30044. doi: 10.1074/jbc.270.50.30036. [DOI] [PubMed] [Google Scholar]
  19. Chien AJ, Carr KM, Shirokov RE, Rios E, Hosey MM. Identification of palmitoylation sites within the L-type calcium channel β2a subunit and effects on channel function. J Biol Chem. 1996;271:26465–26468. doi: 10.1074/jbc.271.43.26465. [DOI] [PubMed] [Google Scholar]
  20. Chien AJ, Gao T, Perez-Reyes E, Hosey MM. Membrane targeting of L-type calcium channels. Role of palmitoylation in the subcellular localization of the β2a subunit. J Biol Chem. 1998;273:23590–23597. doi: 10.1074/jbc.273.36.23590. [DOI] [PubMed] [Google Scholar]
  21. Cohen RM, Foell JD, Balijepalli RC, Shah V, Hell JW, Kamp TJ. Unique modulation of L-type Ca2+ channels by short auxiliary β1d subunit present in cardiac muscle. Am J Physiol. 2005;288:H2363–H2374. doi: 10.1152/ajpheart.00348.2004. [DOI] [PubMed] [Google Scholar]
  22. Cox RH, Lozinskaya IM. Augmented calcium currents in mesenteric artery branches of the spontaneously hypertensive rat. Hypertension. 1995;26:1060–1064. doi: 10.1161/01.hyp.26.6.1060. [DOI] [PubMed] [Google Scholar]
  23. Cox RH, Rusch NJ. New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure. Microcirculation. 2002;9:243–257. doi: 10.1038/sj.mn.7800140. [DOI] [PubMed] [Google Scholar]
  24. Cox RH, Folander K, Swanson R. Differential expression of voltage-gated K+ channel genes in arteries from spontaneously hypertensive and Wistar–Kyoto rats. Hypertension. 2001;37:1315–1322. doi: 10.1161/01.hyp.37.5.1315. [DOI] [PubMed] [Google Scholar]
  25. Cox RH, Lozinskaya I, Matsuda K, Dietz NJ. Ramipril treatment alters Ca2+ and K+ channels in small mesenteric arteries from Wistar–Kyoto and spontaneously hypertensive rats. Am J Hypertens. 2002;15:879–890. [PubMed] [Google Scholar]
  26. Curtis BM, Catterall WA. Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules. Biochemistry. 1984;23:2113–2118. doi: 10.1021/bi00305a001. [DOI] [PubMed] [Google Scholar]
  27. Curtis BM, Catterall WA. Phosphorylation of the calcium antagonist receptor of the voltage-sensitive calcium channel by cAMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1985;82:2528–2532. doi: 10.1073/pnas.82.8.2528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Davidoff AJ, Maki TM, Ellingsen O, Marsh JD. Expression of calcium channels in adult cardiac myocytes is regulated by calcium. J Mol Cell Cardiol. 1997;29:1791–1803. doi: 10.1006/jmcc.1997.0406. [DOI] [PubMed] [Google Scholar]
  29. De Jongh KS, Warner C, Catterall WA. Subunits of purified calcium channels. α2 and δ are encoded by the same gene. J Biol Chem. 1990;265:14738–14741. [PubMed] [Google Scholar]
  30. Dolphin AC. β Subunits of voltage-gated calcium channels. J Bioenerg Biomembranes. 2003;35:599–620. doi: 10.1023/b:jobb.0000008026.37790.5a. [DOI] [PubMed] [Google Scholar]
  31. Dustan HP. Hypertension treatment. Its past and (perhaps) its future. Arch Intern Med. 1996;156:1913–1914. doi: 10.1001/archinte.156.17.1913. [DOI] [PubMed] [Google Scholar]
  32. Dworkin LD, Feiner HD. Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension. J Clin Invest. 1986;77:797–809. doi: 10.1172/JCI112377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Fan QI, Vanderpool KM, O’Connor J, Marsh JD. Decoy calcium channel β subunits modulate contractile function in myocytes. Mol Cell Biochem. 2003;242:3–10. [PubMed] [Google Scholar]
  34. Feld LG, Van Liew JB, Galaske RG, Boylan JW. Selectivity of renal injury and proteinuria in the spontaneously hypertensive rat. Kidney Int. 1977;12:332–343. doi: 10.1038/ki.1977.120. [DOI] [PubMed] [Google Scholar]
  35. Finlin BS, Crump SM, Satin J, Andres DA. Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases. Proc Natl Acad Sci U S A. 2003;100:14469–14474. doi: 10.1073/pnas.2437756100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Foell JD, Balijepalli RC, Delisle BP, Yunker AM, Robia SL, Walker JW, McEnery MW, January CT, Kamp TJ. Molecular heterogeneity of calcium channel β-subunits in canine and human heart: evidence for differential subcellular localization. Physiol Genomics. 2004;17:183–200. doi: 10.1152/physiolgenomics.00207.2003. [DOI] [PubMed] [Google Scholar]
  37. Gauthier-Rein KM, Rusch NJ. Distinct endothelial impairment in coronary microvessels from hypertensive Dahl rats. Hypertension. 1998;31:328–334. doi: 10.1161/01.hyp.31.1.328. [DOI] [PubMed] [Google Scholar]
  38. Gebremedhin D, Fenoy FJ, Harder DR, Roman RJ. Enhanced vascular tone in the renal vasculature of spontaneously hypertensive rats. Hypertension. 1990;16:648–654. doi: 10.1161/01.hyp.16.6.648. [DOI] [PubMed] [Google Scholar]
  39. Geib S, Sandoz G, Cornet V, Mabrouk K, Fund-Saunier O, Bichet D, Villaz M, Hoshi T, Sabatier JM, De Waard M. The interaction between the I–II loop and the III–IV loop of Cav2.1 contributes to voltage-dependent inactivation in a β-dependent manner. J Biol Chem. 2002;277:10003–10013. doi: 10.1074/jbc.M106231200. [DOI] [PubMed] [Google Scholar]
  40. Gerster U, Neuhuber B, Groschner K, Striessnig J, Flucher BE. Current modulation and membrane targeting of the calcium channel α1C subunit are independent functions of the β subunit. J Physiol. 1999;517:353–368. doi: 10.1111/j.1469-7793.1999.0353t.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Godfraind T, Kazda S, Wibo M. Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats. Circ Res. 1991;68:674–682. doi: 10.1161/01.res.68.3.674. [DOI] [PubMed] [Google Scholar]
  42. Goligorsky MS, Colflesh D, Gordienko D, Moore LC. Branching points of renal resistance arteries are enriched in L-type calcium channels and initiate vasoconstriction. Am J Physiol. 1995;268:F251–F257. doi: 10.1152/ajprenal.1995.268.2.F251. [DOI] [PubMed] [Google Scholar]
  43. Gong HC, Hang J, Kohler W, Li L, Su TZ. Tissue-specific expression and gabapentin-binding properties of calcium channel α2δ subunit subtypes. J Membr Biol. 2001;184:35–43. doi: 10.1007/s00232-001-0072-7. [DOI] [PubMed] [Google Scholar]
  44. Gregg RG, Messing A, Strube C, Beurg M, Moss R, Behan M, Sukhareva M, Haynes S, Powell JA, Coronado R, Powers PA. Absence of the β subunit (cchb1) of the skeletal muscle dihydropyridine receptor alters expression of the α1 subunit and eliminates excitation–contraction coupling. Proc Natl Acad Sci U S A. 1996;93:13961–13966. doi: 10.1073/pnas.93.24.13961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Gurnett CA, Felix R, Campbell KP. Extracellular interaction of the voltage-dependent Ca2+ channel α2δ and α1 subunits. J Biol Chem. 1997;272:18508–18512. doi: 10.1074/jbc.272.29.18508. [DOI] [PubMed] [Google Scholar]
  46. Harder DR, Brann L, Halpern W. Altered membrane electrical properties of smooth muscle cells from small cerebral arteries of hypertensive rats. Blood Vessels. 1983;20:154–160. doi: 10.1159/000158469. [DOI] [PubMed] [Google Scholar]
  47. Harder DR, Smeda J, Lombard J. Enhanced myogenic depolarization in hypertensive cerebral arterial muscle. Circ Res. 1985;57:319–322. doi: 10.1161/01.res.57.2.319. [DOI] [PubMed] [Google Scholar]
  48. Harry JB, Kobrinsky E, Abernethy DR, Soldatov NM. New short splice variants of the human cardiac Cavβ2 subunit: redefining the major functional motifs implemented in modulation of the Cav1.2 channel. J Biol Chem. 2004;279:46367–46372. doi: 10.1074/jbc.M409523200. [DOI] [PubMed] [Google Scholar]
  49. Hayashi K, Epstein M, Loutzenhiser R. Enhanced myogenic responsiveness of renal interlobular arteries in spontaneously hypertensive rats. Hypertension. 1992;19:153–160. doi: 10.1161/01.hyp.19.2.153. [DOI] [PubMed] [Google Scholar]
  50. Hayashi K, Epstein M, Saruta T. Altered myogenic responsiveness of the renal microvasculature in experimental hypertension. J Hypertens. 1996;14:1387–1401. doi: 10.1097/00004872-199612000-00002. [DOI] [PubMed] [Google Scholar]
  51. Helguera G, Olcese R, Song M, Toro L, Stefani E. Tissue-specific regulation of Ca2+ channel protein expression by sex hormones. Biochim Biophys Acta. 2002;1569:59–66. doi: 10.1016/s0304-4165(01)00234-3. [DOI] [PubMed] [Google Scholar]
  52. Herlitze S, Hockerman GH, Scheuer T, Catterall WA. Molecular determinants of inactivation and G protein modulation in the intracellular loop connecting domains I and II of the calcium channel α1A subunit. Proc Natl Acad Sci U S A. 1997;94:1512–1516. doi: 10.1073/pnas.94.4.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Herlitze S, Xie M, Han J, Hummer A, Melnik-Martinez KV, Moreno RL, Mark MD. Targeting mechanisms of high voltage-activated Ca2+ channels. J Bioenerg Biomembranes. 2003;35:621–637. doi: 10.1023/b:jobb.0000008027.19384.c0. [DOI] [PubMed] [Google Scholar]
  54. Hosey MM, Barhanin J, Schmid A, Vandaele S, Ptasienski J, O’Callahan C, Cooper C, Lazdunski M. Photoaffinity labelling and phosphorylation of a 165 kilodalton peptide associated with dihydropyridine and phenylalkylamine-sensitive calcium channels. Biochem Biophys Res Commun. 1987;147:1137–1145. doi: 10.1016/s0006-291x(87)80188-2. [DOI] [PubMed] [Google Scholar]
  55. Hullin R, Singer-Lahat D, Freichel M, Biel M, Dascal N, Hofmann F, Flockerzi V. Calcium channel β-subunit heterogeneity: functional expression of cloned cDNA from heart, aorta and brain. EMBO J. 1992;11:885–890. doi: 10.1002/j.1460-2075.1992.tb05126.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hullin R, Khan IF, Wirtz S, Mohacsi P, Varadi G, Schwartz A, Herzig S. Cardiac L-type calcium channel β-subunits expressed in human heart have differential effects on single channel characteristics. J Biol Chem. 2003;278:21623–21630. doi: 10.1074/jbc.M211164200. [DOI] [PubMed] [Google Scholar]
  57. Ice KS, Takahashi M, Curtis BM, Catterall WA. Comparison of molecular properties of the voltage-sensitive Ca2+ channel from longitudinal smooth muscle of rabbit ileum with the channel purified from transverse tubules of rabbit skeletal muscle. Circ Res. 1987;61:I24–I29. [PubMed] [Google Scholar]
  58. Inscho EW, Cook AK, Mui V, Imig JD. Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction. Hypertension. 1998;31:421–428. doi: 10.1161/01.hyp.31.1.421. [DOI] [PubMed] [Google Scholar]
  59. Jay SD, Sharp AH, Kahl SD, Vedvick TS, Harpold MM, Campbell KP. Structural characterization of the dihydropyridine-sensitive calcium channel α2-subunit and the associated δ peptides. J Biol Chem. 1991;266:3287–3293. [PubMed] [Google Scholar]
  60. Jurkat-Rott K, Lehmann-Horn F. The impact of splice isoforms on voltage-gated calcium channel α1 subunits. J Physiol. 2004;554:609–619. doi: 10.1113/jphysiol.2003.052712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Kamada Y, Yamada Y, Yamakage M, Nagashima M, Tsutsuura M, Kobayashi T, Seki S, Namiki A, Tohse N. Single-channel activity of L-type Ca2+ channels reconstituted with the β2C subunit cloned from the rat heart. Eur J Pharmacol. 2004;487:37–45. doi: 10.1016/j.ejphar.2004.01.016. [DOI] [PubMed] [Google Scholar]
  62. Kang MG, Chen CC, Felix R, Letts VA, Frankel WN, Mori Y, Campbell KP. Biochemical and biophysical evidence for γ2 subunit association with neuronal voltage-activated Ca2+ channels. J Biol Chem. 2001;276:32917–32924. doi: 10.1074/jbc.M100787200. [DOI] [PubMed] [Google Scholar]
  63. Klugbauer N, Dai S, Specht V, Lacinova L, Marais E, Bohn G, Hofmann F. A family of γ-like calcium channel subunits. FEBS Lett. 2000;470:189–197. doi: 10.1016/s0014-5793(00)01306-5. [DOI] [PubMed] [Google Scholar]
  64. Klugbauer N, Marais E, Hofmann F. Calcium channel α2δ subunits: differential expression, function, and drug binding. J Bioenerg Biomembranes. 2003;35:639–647. doi: 10.1023/b:jobb.0000008028.41056.58. [DOI] [PubMed] [Google Scholar]
  65. Kobrinsky E, Kepplinger KJ, Yu A, Harry JB, Kahr H, Romanin C, Abernethy DR, Soldatov NM. Voltage-gated rearrangements associated with differential β-subunit modulation of the L-type Ca2+ channel inactivation. Biophys J. 2004;87:844–857. doi: 10.1529/biophysj.104.041152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Kobrinsky E, Tiwari S, Maltsev VA, Harry JB, Lakatta E, Abernethy DR, Soldatov NM. Differential role of the α1C subunit tails in regulation of the Cav1.2 channel by membrane potential, β subunits, and Ca2+ ions. J Biol Chem. 2005;280:12474–12485. doi: 10.1074/jbc.M412140200. [DOI] [PubMed] [Google Scholar]
  67. Koch WJ, Ellinor PT, Schwartz A. cDNA cloning of a dihydropyridine-sensitive calcium channel from rat aorta. Evidence for the existence of alternatively spliced forms. J Biol Chem. 1990;265:17786–17791. [PubMed] [Google Scholar]
  68. Lee A, Wong ST, Gallagher D, Li B, Storm DR, Scheuer T, Catterall WA. Ca2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature. 1999;399:155–159. doi: 10.1038/20194. [DOI] [PubMed] [Google Scholar]
  69. Leung AT, Imagawa T, Campbell KP. Structural characterization of the 1,4-dihydropyridine receptor of the voltage-dependent Ca2+ channel from rabbit skeletal muscle. Evidence for two distinct high molecular weight subunits. J Biol Chem. 1987;262:7943–7946. [PubMed] [Google Scholar]
  70. Liang H, DeMaria CD, Erickson MG, Mori MX, Alseikhan BA, Yue DT. Unified mechanisms of Ca2+ regulation across the Ca2+ channel family. Neuron. 2003;39:951–960. doi: 10.1016/s0896-6273(03)00560-9. [DOI] [PubMed] [Google Scholar]
  71. Liao P, Yu D, Lu S, Tang Z, Liang MC, Zeng S, Lin W, Soong TW. Smooth muscle-selective alternatively spliced exon generates functional variation in Cav1.2 calcium channels. J Biol Chem. 2004;279:50329–50335. doi: 10.1074/jbc.M409436200. [DOI] [PubMed] [Google Scholar]
  72. Lozinskaya IM, Cox RH. Effects of age on Ca2+ currents in small mesenteric artery myocytes from Wistar–Kyoto and spontaneously hypertensive rats. Hypertension. 1997;29:1329–1336. doi: 10.1161/01.hyp.29.6.1329. [DOI] [PubMed] [Google Scholar]
  73. Maki T, Gruver EJ, Davidoff AJ, Izzo N, Toupin D, Colucci W, Marks AR, Marsh JD. Regulation of calcium channel expression in neonatal myocytes by catecholamines. J Clin Invest. 1996;97:656–663. doi: 10.1172/JCI118462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002;20:1461–1464. doi: 10.1097/00004872-200208000-00001. [DOI] [PubMed] [Google Scholar]
  75. Marais E, Klugbauer N, Hofmann F. Calcium channel α2δ subunits-structure and Gabapentin binding. Mol Pharmacol. 2001;59:1243–1248. doi: 10.1124/mol.59.5.1243. [DOI] [PubMed] [Google Scholar]
  76. Martens JR, Gelband CH. Alterations in rat interlobar artery membrane potential and K+ channels in genetic and nongenetic hypertension. Circ Res. 1996;79:295–301. doi: 10.1161/01.res.79.2.295. [DOI] [PubMed] [Google Scholar]
  77. McGee AW, Nunziato DA, Maltez JM, Prehoda KE, Pitt GS, Bredt DS. Calcium channel function regulated by the SH3–GK module in β subunits. Neuron. 2004;42:89–99. doi: 10.1016/s0896-6273(04)00149-7. [DOI] [PubMed] [Google Scholar]
  78. Meir A, Dolphin AC. Kinetics and Gβγ modulation of Cav2.2 channels with different auxiliary β subunits. Pflugers Arch. 2002;444:263–275. doi: 10.1007/s00424-002-0803-3. [DOI] [PubMed] [Google Scholar]
  79. Miyamori I, Yasuhara S, Matsubara T, Takasaki H, Takeda R. Effects of a calcium entry blocker on cerebral circulation in essential hypertension. J Clin Hypertens. 1987;3:528–535. [PubMed] [Google Scholar]
  80. Moosmang S, Schulla V, Welling A, Feil R, Feil S, Wegener JW, Hofmann F, Klugbauer N. Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J. 2003;22:6027–6034. doi: 10.1093/emboj/cdg583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Moss FJ, Viard P, Davies A, Bertaso F, Page KM, Graham A, Canti C, Plumpton M, Plumpton C, Clare JJ, Dolphin AC. The novel product of a five-exon stargazin-related gene abolishes CaV2.2 calcium channel expression. EMBO J. 2002;21:1514–1523. doi: 10.1093/emboj/21.7.1514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Murakami M, Yamamura H, Suzuki T, Kang MG, Ohya S, Murakami A, Miyoshi I, Sasano H, Muraki K, Hano T, Kasai N, Nakayama S, Campbell KP, Flockerzi V, Imaizumi Y, Yanagisawa T, Iijima T. Modified cardiovascular L-type channels in mice lacking the voltage-dependent Ca2+ channel β3 subunit. J Biol Chem. 2003;278:43261–43267. doi: 10.1074/jbc.M211380200. [DOI] [PubMed] [Google Scholar]
  83. Muth JN, Varadi G, Schwartz A. Use of transgenic mice to study voltage-dependent Ca2+ channels. Trends Pharmacol Sci. 2001;22:526–532. doi: 10.1016/s0165-6147(00)01797-1. [DOI] [PubMed] [Google Scholar]
  84. Narayanan J, Imig M, Roman RJ, Harder DR. Pressurization of isolated renal arteries increases inositol trisphosphate and diacylglycerol. Am J Physiol. 1994;266:H1840–H1845. doi: 10.1152/ajpheart.1994.266.5.H1840. [DOI] [PubMed] [Google Scholar]
  85. Narita H, Nagao T, Yabana H, Yamaguchi I. Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar–Kyoto rats. J Pharmacol Exp Ther. 1983;227:472–477. [PubMed] [Google Scholar]
  86. Nattel S, Li D. Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ Res. 2000;87:440–447. doi: 10.1161/01.res.87.6.440. [DOI] [PubMed] [Google Scholar]
  87. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage-dependence of arterial smooth muscle tone. Am J Physiol. 1990;259:C3–C18. doi: 10.1152/ajpcell.1990.259.1.C3. [DOI] [PubMed] [Google Scholar]
  88. Ohya Y, Abe I, Fujii K, Takata Y, Fujishima M. Voltage-dependent Ca2+ channels in resistance arteries from spontaneously hypertensive rats. Circ Res. 1993;73:1090–1099. doi: 10.1161/01.res.73.6.1090. [DOI] [PubMed] [Google Scholar]
  89. Ohya Y, Tsuchihashi T, Kagiyama S, Abe I, Fujishima M. Single L-type calcium channels in smooth muscle cells from resistance arteries of spontaneously hypertensive rats. Hypertension. 1998;31:1125–1129. doi: 10.1161/01.hyp.31.5.1125. [DOI] [PubMed] [Google Scholar]
  90. Olcese R, Qin N, Schneider T, Neely A, Wei X, Stefani E, Birnbaumer L. The amino terminus of a calcium channel β subunit sets rates of channel inactivation independently of the subunit’s effect on activation. Neuron. 1994;13:1433–1438. doi: 10.1016/0896-6273(94)90428-6. [DOI] [PubMed] [Google Scholar]
  91. Olson JL, Wilson SK, Heptinstall RH. Relation of glomerular injury to preglomerular resistance in experimental hypertension. Kidney Int. 1986;29:849–857. doi: 10.1038/ki.1986.76. [DOI] [PubMed] [Google Scholar]
  92. Pang L, Koren G, Wang Z, Nattel S. Tissue-specific expression of two human Cav1.2 isoforms under the control of distinct 5′ flanking regulatory elements. FEBS Lett. 2003;546:349–354. doi: 10.1016/s0014-5793(03)00629-x. [DOI] [PubMed] [Google Scholar]
  93. Pesic A, Madden JA, Pesic M, Rusch NJ. High blood pressure upregulates arterial L-type Ca2+ channels: is membrane depolarization the signal? Circ Res. 2004;94:e97–e104. doi: 10.1161/01.RES.0000131495.93500.3c. [DOI] [PubMed] [Google Scholar]
  94. Pesic A, Pesic M, Gordon JB, Rusch NJ. Upregulation of Ca2+ channel α and β subunits in pulmonary arteries of neonatal piglets exposed to chronic hypoxia. FASEB J. 2005;19:A1331. [Google Scholar]
  95. Peterson BZ, DeMaria CD, Adelman JP, Yue DT. Calmodulin is the Ca2+ sensor for Ca2+-dependent inactivation of L-type calcium channels. Neuron. 1999;22:549–558. doi: 10.1016/s0896-6273(00)80709-6. [DOI] [PubMed] [Google Scholar]
  96. Pichler M, Cassidy TN, Reimer D, Haase H, Kraus R, Ostler D, Striessnig J. β Subunit heterogeneity in neuronal L-type Ca2+ channels. J Biol Chem. 1997;272:13877–13882. doi: 10.1074/jbc.272.21.13877. [DOI] [PubMed] [Google Scholar]
  97. Pratt PF, Bonnet S, Ludwig LM, Bonnet P, Rusch NJ. Upregulation of L-type Ca2+ channels in mesenteric and skeletal arteries of SHR. Hypertension. 2002;40:214–219. doi: 10.1161/01.hyp.0000025877.23309.36. [DOI] [PubMed] [Google Scholar]
  98. Pratt PF, Popovic A, Pesic M, Rusch NJ. Functional expression of L-type calcium channels in cultured rat renal smooth muscle cells. FASEB J. 2003;17:A1049. [Google Scholar]
  99. Qin N, Olcese R, Bransby M, Lin T, Birnbaumer L. Ca2+-induced inhibition of the cardiac Ca2+ channel depends on calmodulin. Proc Natl Acad Sci U S A. 1999;96:2435–2438. doi: 10.1073/pnas.96.5.2435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Ruiz-Velasco V, Beatriz-Mayer M, Inscho EW, Hymel LJ. Modulation of dihydropyridine receptors in vascular smooth muscle cells by membrane potential and cell proliferation. Eur J Pharmacol. 1994;268:311–318. doi: 10.1016/0922-4106(94)90055-8. [DOI] [PubMed] [Google Scholar]
  101. Saada NI, Dai B, Echetebu C, Sarna SK, Palade P. Smooth muscle uses another promoter to express primarily a form of human Cav1.2 L-type calcium channel different from the principal heart form. Biochem Biophys Res Commun. 2003;302:23–28. doi: 10.1016/s0006-291x(03)00097-4. [DOI] [PubMed] [Google Scholar]
  102. Saada NI, Carrillo ED, Dai B, Wang Wen-ze, Dettbarn C, Sanchez J, Palade P. Expression of multiple CaV1.2 transcripts in rat tissues mediated by different promoters. Cell Calcium. 2005;37:301–309. doi: 10.1016/j.ceca.2004.11.003. [DOI] [PubMed] [Google Scholar]
  103. Safa P, Boulter J, Hales TG. Functional properties of Cav1.3 (α1D) L-type Ca2+ channel splice variants expressed by rat brain and neuroendocrine GH3 cells. J Biol Chem. 2001;276:38727–38737. doi: 10.1074/jbc.M103724200. [DOI] [PubMed] [Google Scholar]
  104. Simard JM, Li X, Tewari K. Increase in functional Ca2+ channels in cerebral smooth muscle with renal hypertension. Circ Res. 1998;82:1330–1337. doi: 10.1161/01.res.82.12.1330. [DOI] [PubMed] [Google Scholar]
  105. Sipos I, Pika-Hartlaub U, Hofmann F, Flucher BE, Melzer W. Effects of the dihydropyridine receptor subunits γ and α2δ on the kinetics of heterologously expressed L-type Ca2+ channels. Pflugers Arch. 2000;439:691–699. doi: 10.1007/s004249900201. [DOI] [PubMed] [Google Scholar]
  106. Smeda JS, King S. Stroke development in stroke-prone spontaneously hypertensive rats alters the ability of cerebrovascular muscle to utilize internal Ca2+ to elicit constriction. Stroke. 2003;34:1491–1496. doi: 10.1161/01.STR.0000073797.91891.9E. [DOI] [PubMed] [Google Scholar]
  107. Spaetgens RL, Zamponi GW. Multiple structural domains contribute to voltage-dependent inactivation of rat brain α1E calcium channels. J Biol Chem. 1999;274:22428–22436. doi: 10.1074/jbc.274.32.22428. [DOI] [PubMed] [Google Scholar]
  108. Stekiel WJ, Contney SJ, Lombard JH. Small vessel membrane potential, sympathetic input, and electrogenic pump rate in SHR. Am J Physiol. 1986;250:C547–C556. doi: 10.1152/ajpcell.1986.250.4.C547. [DOI] [PubMed] [Google Scholar]
  109. Stekiel WJ, Contney SJ, Rusch NJ. Altered β-receptor control of in situ membrane potential in hypertensive rats. Hypertension. 1993;21:1005–1009. doi: 10.1161/01.hyp.21.6.1005. [DOI] [PubMed] [Google Scholar]
  110. Takata Y, Hutchinson JS. Exaggerated hypotensive responses to calcium antagonists in spontaneously hypertensive rats. Clin Exp Hypertens, Part A Theory Pract. 1983;5:827–847. doi: 10.3109/10641968309081811. [DOI] [PubMed] [Google Scholar]
  111. Takimoto K, Li D, Nerbonne JM, Levitan ES. Distribution, splicing and glucocorticoid-induced expression of cardiac α1C and α1D voltage-gated Ca2+ channel mRNAs. J Mol Cell Cardiol. 1997;29:3035–3042. doi: 10.1006/jmcc.1997.0532. [DOI] [PubMed] [Google Scholar]
  112. Tobin AA, T NL, Madden JA, Pesic A, Rusch NJ. Loss of voltage-gated potassium channels in the cerebral arteries of hypertensive rats. FASEB J. 2004;18:A268. [Google Scholar]
  113. Vaghy PL, Striessnig J, Miwa K, Knaus HG, Itagaki K, McKenna E, Glossmann H, Schwartz A. Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations. J Biol Chem. 1987;262:14337–14342. [PubMed] [Google Scholar]
  114. Viard P, Butcher AJ, Halet G, Davies A, Nurnberg B, Heblich F, Dolphin AC. PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat Neurosci. 2004;7:939–946. doi: 10.1038/nn1300. [DOI] [PubMed] [Google Scholar]
  115. Waeber B. The treatment of arterial hypertension: is it a simple routine? Arch Mal Coeur Vaiss. 2002;95:3–6. [PubMed] [Google Scholar]
  116. Wang J, Juhaszova M, Rubin LJ, Yuan XJ. Hypoxia inhibits gene expression of voltage-gated K+ channel α subunits in pulmonary artery smooth muscle cells. J Clin Invest. 1997;100:2347–2353. doi: 10.1172/JCI119774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Wang HX, Davis MJ, Rajanayagam MA, Potocnik SJ, Hill MA. Myogenic reactivity of rat epineurial arterioles: potential role in local vasoregulatory events. Am J Physiol. 1999;277:H144–H151. doi: 10.1152/ajpheart.1999.277.1.H144. [DOI] [PubMed] [Google Scholar]
  118. Wei X, Pan S, Lang W, Kim H, Schneider T, Perez-Reyes E, Birnbaumer L. Molecular determinants of cardiac Ca2+ channel pharmacology. Subunit requirement for the high affinity and allosteric regulation of dihydropyridine binding. J Biol Chem. 1995;270:27106–27111. doi: 10.1074/jbc.270.45.27106. [DOI] [PubMed] [Google Scholar]
  119. Welling A, Ludwig A, Zimmer S, Klugbauer N, Flockerzi V, Hofmann F. Alternatively spliced IS6 segments of the α1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels. Circ Res. 1997;81:526–532. doi: 10.1161/01.res.81.4.526. [DOI] [PubMed] [Google Scholar]
  120. Wilde DW, Furspan PB, Szocik JF. Calcium current in smooth muscle cells from normotensive and genetically hypertensive rats. Hypertension. 1994;24:739–746. doi: 10.1161/01.hyp.24.6.739. [DOI] [PubMed] [Google Scholar]
  121. Xie J, Nagle GT, Childs GV, Ritchie AK. Expression of the L-type Ca2+ channel in AtT-20 cells is regulated by cyclic AMP. Neuroendocrinology. 1999;70:1–9. doi: 10.1159/000054454. [DOI] [PubMed] [Google Scholar]
  122. Yuan XJ, Wang J, Juhaszova M, Gaine SP, Rubin LJ. Attenuated K+ channel gene transcription in primary pulmonary hypertension. Lancet. 1998a;351:726–727. doi: 10.1016/S0140-6736(05)78495-6. [DOI] [PubMed] [Google Scholar]
  123. Yuan XJ, Wang J, Juhaszova M, Golovina VA, Rubin LJ. Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells. Am J Physiol. 1998b;274:L621–L635. doi: 10.1152/ajplung.1998.274.4.L621. [DOI] [PubMed] [Google Scholar]
  124. Zhang JF, Ellinor PT, Aldrich RW, Tsien RW. Molecular determinants of voltage-dependent inactivation in calcium channels. Nature. 1994;372:97–100. doi: 10.1038/372097a0. [DOI] [PubMed] [Google Scholar]
  125. Zuhlke RD, Pitt GS, Deisseroth K, Tsien RW, Reuter H. Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature. 1999;399:159–162. doi: 10.1038/20200. [DOI] [PubMed] [Google Scholar]

RESOURCES